Literature DB >> 24316518

Dietary glycotoxins exacerbate progression of experimental fatty liver disease.

Christopher Leung1, Chandana B Herath2, Zhiyuan Jia2, Michelle Goodwin3, Kai Yan Mak2, Matthew J Watt4, Josephine M Forbes5, Peter W Angus3.   

Abstract

BACKGROUND & AIMS: Advanced glycation end-products (AGEs) levels are high in western diets and contribute to tissue injury via activation of RAGE (receptor for AGEs) and generation of reactive oxygen species (ROS). Here, we determined if high dietary AGE intake worsens progression of non-alcoholic fatty liver disease (NAFLD).
METHODS: Male Sprague Dawley rats were fed a methionine choline deficient (MCD) diet for 6 weeks before 6 weeks of a high AGE MCD diet through baking. They were compared with animals on MCD diet or a methionine choline replete (MCR) diet alone for 12 weeks. Hepatic ROS, triglycerides, biochemistry, picro-sirius morphometry, hepatic mRNA expression and immunohistochemistry were determined. Primary hepatic stellate cells (HSCs) from both MCR and MCD animals were exposed to AGEs. ROS, proliferation and mRNA expression were determined.
RESULTS: The high AGE MCD diet increased hepatic AGE content and elevated triglycerides, NADPH dependent superoxide production, HNE adducts, steatosis, steatohepatitis (CD43, IL-6, TNF-α) and fibrosis (α-SMA, CTGF, COL1A, picrosirius) compared to MCD alone. In HSCs, AGEs significantly increased ROS production, bromodeoxyuridine proliferation and MCP-1, IL-6, α-SMA, and RAGE expression in HSCs from MCD but not MCR animals. These effects were abrogated by RAGE or NADPH oxidase blockade.
CONCLUSIONS: In the MCD model of NAFLD, high dietary AGEs increases hepatic AGE content and exacerbates liver injury, inflammation, and liver fibrosis via oxidative stress and RAGE dependent profibrotic effects of AGEs on activated HSCs. This suggests that pharmacological and dietary strategies targeting the AGE/RAGE pathway could slow the progression of NAFLD.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  Advanced glycation end-products; Hepatic stellate cell; Non-alcoholic fatty liver disease; Oxidative stress; Steatohepatitis

Mesh:

Substances:

Year:  2013        PMID: 24316518     DOI: 10.1016/j.jhep.2013.11.033

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  30 in total

Review 1.  The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis.

Authors:  Mithun Sharma; Shasikala Mitnala; Ravi K Vishnubhotla; Rathin Mukherjee; Duvvur N Reddy; Padaki N Rao
Journal:  J Clin Exp Hepatol       Date:  2015-02-16

Review 2.  The role of the gut microbiota in NAFLD.

Authors:  Christopher Leung; Leni Rivera; John B Furness; Peter W Angus
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-06-08       Impact factor: 46.802

3.  Dietary consumption of advanced glycation end products and pancreatic cancer in the prospective NIH-AARP Diet and Health Study.

Authors:  Li Jiao; Rachael Stolzenberg-Solomon; Thea Palmer Zimmerman; Zhigang Duan; Liang Chen; Lisa Kahle; Adam Risch; Amy F Subar; Amanda J Cross; Albert Hollenbeck; Helen Vlassara; Gary Striker; Rashmi Sinha
Journal:  Am J Clin Nutr       Date:  2014-11-19       Impact factor: 7.045

Review 4.  Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies.

Authors:  Masayoshi Takeuchi; Jun-Ichi Takino; Akiko Sakasai-Sakai; Takanobu Takata; Tadashi Ueda; Mikihiro Tsutsumi; Hideyuki Hyogo; Sho-Ichi Yamagishi
Journal:  World J Hepatol       Date:  2014-12-27

Review 5.  Advanced Glycation End Products (AGEs) and Chronic Kidney Disease: Does the Modern Diet AGE the Kidney?

Authors:  Amelia K Fotheringham; Linda A Gallo; Danielle J Borg; Josephine M Forbes
Journal:  Nutrients       Date:  2022-06-28       Impact factor: 6.706

6.  Artemisia alleviates AGE-induced liver complications via MAPK and RAGE signaling pathways modulation: a combinatorial study.

Authors:  Hichem Moulahoum; Faezeh Ghorbanizamani; Zineb Khiari; Mohamed Toumi; Yasmina Benazzoug; Kerem Tok; Suna Timur; Figen Zihnioglu
Journal:  Mol Cell Biochem       Date:  2022-05-11       Impact factor: 3.842

Review 7.  Review article: emerging anti-fibrotic therapies in the treatment of non-alcoholic steatohepatitis.

Authors:  M Noureddin; Q M Anstee; R Loomba
Journal:  Aliment Pharmacol Ther       Date:  2016-04-08       Impact factor: 8.171

8.  A carnosine analog mitigates metabolic disorders of obesity by reducing carbonyl stress.

Authors:  Ethan J Anderson; Giulio Vistoli; Lalage A Katunga; Katsuhiko Funai; Luca Regazzoni; T Blake Monroe; Ettore Gilardoni; Luca Cannizzaro; Mara Colzani; Danilo De Maddis; Giuseppe Rossoni; Renato Canevotti; Stefania Gagliardi; Marina Carini; Giancarlo Aldini
Journal:  J Clin Invest       Date:  2018-10-22       Impact factor: 14.808

9.  Association between the soluble receptor for advanced glycation end products (sRAGE) and NAFLD in participants in the Atherosclerosis Risk in Communities Study.

Authors:  Marci Laudenslager; Mariana Lazo; Dan Wang; Elizabeth Selvin; Po-Hung Chen; James S Pankow; Jeanne M Clark
Journal:  Dig Liver Dis       Date:  2021-02-24       Impact factor: 5.165

10.  Choline and Cystine Deficient Diets in Animal Models with Hepatocellular Injury: Evaluation of Oxidative Stress and Expression of RAGE, TNF-α, and IL-1β.

Authors:  Juliana Célia F Santos; Orlando R P de Araújo; Iara B Valentim; Kívia Queiroz de Andrade; Fabiana Andréa Moura; Salete Smaniotto; John Marques dos Santos; Juciano Gasparotto; Daniel P Gelain; Marília O F Goulart
Journal:  Oxid Med Cell Longev       Date:  2015-06-02       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.